medigraphic.com

2016, Number 1

<< Back Next >>

Rev Fac Med UNAM 2016; 59 (1)

HIV infection and AIDS , two worlds that deviate

Torruco GU

Language: Spanish
References: 17
Page: 36-41
PDF size: 3721.49 Kb.


ABSTRACT

Few diseases have received much attention as HIV infection and AIDS, few diseases represent so explicitly the impact of the science on transforming death sentences in hope of life. In HIV Infection scientific developments occur exponentially, the paradigms of care changes all the time and communities are not always adapted at the same speed. This article deals with the transition of the clinic and conceptual issue that HIV/AIDS has experienced last years, in which there is less emphasis on AIDS and a mayor focus on chronic diseases, but above all, this article focuses on the differences in the attention, according to the capacity that the communities have to implement the science developments.


REFERENCES

  1. Office of NIH history. In their own words [internet]. Bethesda MD EUA. NIH. (Citado el 30 de septiembre del 2015). Disponible en https://history.nih.gov/NIHInOwnWords/ index.html

  2. Arellano LM. Estigma y discriminación a personas con VIH [Internet]. México. Centro Nacional para Prevenir la Discriminación; 2008 [citado el 30 de septiembre del 2015]. 30 p. Disponible en http://www.conapred.org.mx/ documentos_cedoc/C-05-A.pdf

  3. Palmisano L, Vella S. A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanità. 2011;47(1):44-8.

  4. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity: review. BMJ 2009;338:a3172.

  5. Marin B, Thiébaut R, Bucher HC, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS 2009;23(13):1743-53.

  6. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada. PLoS ONE. 2013;8(12):e81355.

  7. ART-CC y COHERE. Long-term Mortality in HIVPositive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery. Clin Infect Dis. 2014;58(9): 1312-21.

  8. Jensen-Fangel S, Pedersen L, Pedersen C, Larsen CS, Tauris P, Møller A, Sorensen HT. Low mortality in HIVinfected patients starting highly active antiretroviral therapy: a comparison with the general population. AIDS. 2004;18(1):89-97.

  9. Chanakira E, Goyder EC, Freeman JV, O’Cathain A, Kinghorn G, Jakubovic M. Social and psychosocial factors associated with high-risk sexual behaviour among university students in the United Kingdom: a web-survey. Int J STD AIDS. 2015;26(6):369-78.

  10. Ghys PD, Zaba B, Prins M. Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network. AIDS. 2007;21 Suppl 6:S1-4.

  11. Verguet S, Frithj of Norheim O, Olson ZD, Yamey G, Jamison DT. Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals. Lancet Glob Health. 2014;2:e698-709.

  12. Centro Nacional para la Prevención y el Control del VIH y el sida. La epidemia del VIH y SIDA en México [Internet]. México: Centro Nacional para la Prevención y el Control del VIH y el sida; 2014 (citado 30 de septiembre del 2015) 6 p. Disponible en http://www.censida.salud.gob.mx/descargas/ epidemiologia/L_E_V_S.pdf

  13. Centro Nacional para la Prevención y el Control del VIH y el sida. Informe nacional de avances en la respuesta al VIH y el sida. México: Centro Nacional para la Prevención y el Control del VIH y el sida; 2015 (citado el 30 de septiembre del 2015). 177 p. Disponible en http://www.censida.salud. gob.mx/descargas/ungass/GARPR_Mx2015.pdf

  14. Hernández-Chávez JJ. 2009: 25 años de presencia comunitaria en la respuesta al VIH y al SIDA en México en Córdoba-Villalobos JA, Ponce de León-Rosales S, Valdespino JL eds. 25 años de SIDA en México. Logros y desaciertos. 2009. México. Instituto Nacional de Salud pública: capítulo 17, 303-14.

  15. Infante C, Zarco A, Cuadra SM, Morrison K, Caballero M, Bronfman M, et al. El estigma asociado al VIH/SIDA: el caso de los prestadores de servicios de salud en México. Salud pública Méx. 2006;48(2):141-50.

  16. Joint United Nations Programme on HIV/AIDS. Reducing HIV Stigma and Discrimination: a critical part of national AIDS programmes A resource for national stakeholders in the HIV response [Internet]. Ginebra: Joint United Nations Programme on HIV/AIDS; 2007 (citado 30 de septiembre del 2015) 56p. Disponible en http://www. unaids.org/sites/default/files/media_asset/jc1521_stigmatisation_ en_0.pdf

  17. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361(23):2209-20.




2020     |     www.medigraphic.com